Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1

被引:19
|
作者
Power, Rebecca [1 ]
Nolan, John M. [1 ]
Prado-Cabrero, Alfonso [1 ]
Coen, Robert [2 ]
Roche, Warren [1 ]
Power, Tommy [1 ]
Howard, Alan N. [3 ]
Mulcahy, Riona [4 ,5 ]
机构
[1] Waterford Inst Technol, Sch Hlth Sci, Nutr Res Ctr Ireland, Carriganore House,West Campus, Waterford X91 K0EK, Ireland
[2] St James Hosp, Mercers Inst Res Ageing, Dublin D08 NHY1, Ireland
[3] Howard Fdn, 7 Marfleet Close, Cambridge CB22 5LA, England
[4] Univ Hosp Waterford, Age Related Care Unit, Dunmore Rd, Waterford X91 ER8E, Ireland
[5] Royal Coll Surgeons Ireland, 123 Stephens Green, Dublin D02 YN77, Ireland
来源
JOURNAL OF PERSONALIZED MEDICINE | 2020年 / 10卷 / 02期
关键词
mild cognitive impairment; nutrition; omega-3 fatty acids; antioxidant; carotenoids; vitamin E; cognition; episodic memory; older adults; ageing; ALZHEIMERS-DISEASE; MEDITERRANEAN DIET; DOCOSAHEXAENOIC ACID; MACULAR PIGMENT; OMEGA-3-FATTY-ACID SUPPLEMENTATION; OLDER-ADULTS; DOUBLE-BLIND; DEMENTIA; CAROTENOIDS; MEMORY;
D O I
10.3390/jpm10020043
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Omega-3 fatty acids (omega-3FAs), carotenoids, and vitamin E are important constituents of a healthy diet. While they are present in brain tissue, studies have shown that these key nutrients are depleted in individuals with mild cognitive impairment (MCI) in comparison to cognitively healthy individuals. Therefore, it is likely that these individuals will benefit from targeted nutritional intervention, given that poor nutrition is one of the many modifiable risk factors for MCI. Evidence to date suggests that these nutritional compounds can work independently to optimize the neurocognitive environment, primarily due to their antioxidant and anti-inflammatory properties. To date, however, no interventional studies have examined the potential synergistic effects of a combination of omega-3FAs, carotenoids and vitamin E on the cognitive function of patients with MCI. Individuals with clinically confirmed MCI consumed an omega-3FA plus carotenoid plus vitamin E formulation or placebo for 12 months. Cognitive performance was determined from tasks that assessed global cognition and episodic memory. omega-3FAs, carotenoids, and vitamin E were measured in blood. Carotenoid concentrations were also measured in tissue (skin and retina). Individuals consuming the active intervention (n= 6; median [IQR] age 73.5 [69.5-80.5] years; 50% female) exhibited statistically significant improvements (p< 0.05, for all) in tissue carotenoid concentrations, and carotenoid and omega-3FA concentrations in blood. Trends in improvements in episodic memory and global cognition were also observed in this group. In contrast, the placebo group (n= 7; median [IQR] 72 (69.5-75.5) years; 89% female) remained unchanged or worsened for all measurements (p> 0.05). Despite a small sample size, this exploratory study is the first of its kind to identify trends in improved cognitive performance in individuals with MCI following supplementation with omega-3FAs, carotenoids, and vitamin E.
引用
收藏
页数:29
相关论文
共 50 条
  • [1] A study on nutritional status of patients with mild cognitive impairment
    Nien, Shih Wei
    Lin, I. Hsin
    Wu, Hsiu Chuan
    Yang, Suh Ching
    [J]. ANNALS OF NUTRITION AND METABOLISM, 2023, 79 : 521 - 521
  • [2] Efficacy of a cognitive intervention program in patients with mild cognitive impairment
    Rojas, Galeno J.
    Villar, Veronica
    Iturry, Monica
    Harris, Paula
    Serrano, Cecilia M.
    Herrera, Jorge A.
    Allegri, Ricardo F.
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2013, 25 (05) : 825 - 831
  • [3] RHEA, a Nonpharmacological Cognitive Training Intervention in Patients With Mild Cognitive Impairment A Pilot Study
    Kounti, Fotini
    Bakoglidou, Evaggelia
    Agogiatou, Christina
    Lombardo, Nancy B. Emerson
    Serper, Lynn Lazarus
    Tsolaki, Magda
    [J]. TOPICS IN GERIATRIC REHABILITATION, 2011, 27 (04) : 289 - 300
  • [4] Mild cognitive impairment and vascular cognitive impairment in stroke patients
    Ballard, C
    Stephens, S
    McLaren, A
    Wesnes, K
    Kenny, R
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 123 - 126
  • [5] Impact of cognitive impairment on mild dementia patients and mild cognitive impairment patients and their informants
    Frank, Lori
    Lloyd, Andrew
    Flynn, Jennifer A.
    Kleinman, Leah
    Matza, Louis S.
    Margolis, Mary Kay
    Bowman, Lee
    Bullock, Roger
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2006, 18 (01) : 151 - 162
  • [6] Cognitive activation intervention on mild cognitive impairment subjects and mild demented patients: A pilot-study
    Cammisuli, D.
    Pinori, F.
    Verdiani, C.
    Sportiello, Timpano M.
    [J]. PSYCHOLOGY & HEALTH, 2009, 24 : 118 - 118
  • [7] Early intervention for mild cognitive impairment: a randomised controlled trial
    Kinsella, G. J.
    Mullaly, E.
    Rand, E.
    Ong, B.
    Burton, C.
    Price, S.
    Phillips, M.
    Storey, E.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (07): : 730 - 736
  • [8] Mild cognitive impairment and subjective cognitive impairment
    Takeda, Masatoshi
    Morihara, Takashi
    Okochi, Masayasu
    Sadik, Golam
    Tanaka, Toshihisa
    [J]. PSYCHOGERIATRICS, 2008, 8 (04) : 155 - 160
  • [9] Nutritional status in hospitalized elderly patients with mild cognitive impairment
    Orsitto, Giuseppe
    Fulvio, Franco
    Tria, Domenico
    Turi, Vincenzo
    Venezia, Amedeo
    Manca, Cosimo
    [J]. CLINICAL NUTRITION, 2009, 28 (01) : 100 - 102
  • [10] Cognitive rehabilitation in patients with mild cognitive impairment
    Kurz, Alexander
    Pohl, Corina
    Ramsenthaler, Michaela
    Sorg, Christian
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 24 (02) : 163 - 168